Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic
Authors
Ravi N. Sharaf (ORCID: https://orcid.org/0000-0002-6905-9823)
Muhammad Danyal Ahsan (ORCID: https://orcid.org/0000-0001-8633-8931)
Paul J. Christos (ORCID: https://orcid.org/0000-0002-3211-9503)
Melissa Kristen Frey (ORCID: https://orcid.org/0000-0002-6705-1211)
Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic
Ravi N. Sharaf, Muhammad Danyal Ahsan, Paul J. Christos, Melissa Kristen Frey et al.
Citations
2 citations
Journal
BMJ Open
Topics
BRCA gene mutations in cancer
Field-Weighted Citation Impact (FWCI)
1.10
article
Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic
Ravi N. Sharaf, Muhammad Danyal Ahsan, Paul J. Christos, Melissa Kristen Frey, Leslie Bull, Sarah R. Levi, Isabelle Chandler, Auja McDougale, Denise Howard, Emily Webster, Benjamin Grant
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(9)
Institutions
Tufts University (US), NewYork–Presbyterian Brooklyn Methodist Hospital (US), Cornell University (US), Weill Cornell Medicine (US)
Funders
Patient-Centered Outcomes Research Institute, Weill Cornell Medical College, National Cancer Institute